TGFB1 and neoplasm: TGF-β’s function as a tumor suppressor appeared in 1995 through the identification of TGF-β receptor mutations in human colon carcinoma with microsatellite instability [31], and the tumor suppressive function of TGF-β was further tested in mouse studies [32,33].